ArticleClinical genitourinary cancer2022

Impact of renin-angiotensin system inhibitors on outcomes in patients with metastatic renal cell carcinoma treated with immune-checkpoint inhibitors.

Pier Vitale Nuzzo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.